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Rubinstein-Taybi Syndrome is a rare genetic disorder with characteristic features 
including downward slanting palpebral fissures, broad thumbs and halluces, 
and mental retardation. Systemic features may involve cardiac, auditory, 
ophthalmic, endocrine, nervous, renal and respiratory systems. This syndrome 
is sporadic in nature and has been linked to microdeletion at 16p 13.3 encoding 
CREB-binding protein gene (CREBBP). We report a 15-years-old girl, a known 
case of chronic renal failure, with downward slanting palpebral fissures toward 
the ears, hypertelorism, short stature, beaked nose, micrognathia, strabismus, 
dental anomalies, large toes, broad thumbs, and mental retardation.
Key words: Rubinstein-Taybi syndrome; chromosome 16p 13.3; mental 
retardation; CBP gene.
Introduction
Attention to detect neurodevelopmental delay in pediatric neurology services has a 
great importance to early intervention of developmental delay in children (1,2,3).
According to this, diagnosis of different genetic syndromes with neurodevelopmental 
delay is invaluable.
Rubinstein- Taybi Syndrome (RSTS) was initially reported by Michail et al. in 
1957 as the broad thumb-hallux syndrome and then was described by Rubinstein 
and Taybi in 1963 (4) in children with broad thumbs and toes, facial abnormalities 
and short stature. Since then, there have been over 250 cases documented in the 
literature. It has been estimated that 1 per 300-500 institutionalized persons with 
mental retardation over age 5 have this syndrome. Male and female individuals are 
affected at equal rates (5).
Typical facial features include downward slanting palpebral fissures toward the 
ears, hypertelorism, long eyelashes, high arched eyebrows, prominent nose, and 
malpositioned ears with dysplastic helices. In addition, characteristic skeletal 
findings are broad short terminal phalanges of the thumbs and halluces, and 
postnatal growth retardation with head circumference below the fiftieth percentile. 
Dermatologic features include capillary malformation in approximately 50 percent 
of patients and higher incidence of keloid formation (6) and pilomatricomas (7).
There may be systemic involvement of multiple organ systems. Of children with 
RSTS, 24-38 percent have cardiac abnormalities including atrial and ventricular 
septal defects, patent ductus arteriosus, coarctation of the aorta, pulmonic stenosis, 
and bicuspid aortic valve abnormalities (8). Feeding difficulties and gastroesophageal 
reflux disease require aggressive treatment in young children to prevent nutritional 
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and growth deficits. Cryptorchidism affects 78-100 
percent of the male infants (9). There is an increased 
incidence of benign and malignant tumors as well as 
leukemia and lymphoma (6,10). Other organ systems 
that may be involved include auditory, ophthalmic, 
endocrine, neurologic, respiratory (9) and renal systems.
Rubinsten-Taybi Syndrome is associated with a mutation 
in the CREB-binding protein gene (CREBBP) located 
on chromosome 16p 13.3. CREBBP which is essential to 
normal development. It has been identified as a nuclear 
protein that participates as a coactivator in cyclic AMP-
regulated gene expression. The precise relationship 
between microdeletion in the CREBBP and the phenotype 
of Rubinstein-Taybi is yet to be elucidated (11,12).
The pediatric neurologic and nephrologic community 
should be aware of the syndrome and its associated 
complications to manage patients.
The purpose of this case report was to provide more 
information on RSTS and its associated complications. 
In this report, we introduce a case with a high level of 
serum creatinine as a known case of chronic renal failure. 
Case report 
A 15-years-old girl was admitted for the follow-up of 
her renal problems as a known case of chronic renal 
failure (CRF) with a high plasma level of BUN and 
creatinine. The clinical history of the patient revealed 
that the developmental milestones were delayed and 
she had history of neonatal distress and respiratory 
infections during infancy. She went to school but had 
educational problems. Her parents were consanguineous. 
She underwent surgical repair (cystoplasty) because 
of vesicoureteral reflux and neurogenic bladder during 
childhood but because her parents did not cooperate, 
she was neglected and her problems progressed and 
became complicated to CRF. She had obstipation and 
prolonged constipation since infancy. She had a history 
of intermittent fever due to recurrent urinary tract 
infection during infancy. 
The patient had a distinctive facial appearance with 
hypertelorism, a broad nasal bridge, a beaked nose, 
micrognathia, microcephaly, smile grimacing, a narrow 
and high arch palate, dental anomalies (different size 
and abnormal size and shape), antimongoloid palpebral 
fissures, strabismus, heavy and highly arched eyebrows 
and long eyelashes (Fig.1, 2).
On examination, short stature (short height and low 
weight), mental retardation and physical growth delay, 
stature under 50th percentile, head circumference under 
50th percentile, hyperextensible joints of hands and 
feet, broad thumbs and large toes, and motor, mental, 
language and social retardation were noted (Fig.3, 4, 5)
Fig 1:Patient’s hypertelorism,high arched eyebrows, Dental 
anomalies(different size, abnormal size and shape) 
Fig2: Patient’s Long eyeshades
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Fig 4, 5: Our case in comparison with another girl of 
the same age - Short stature (patients has microcephaly, 
Beaked nose, Micrognathia))
We found some properties in this patient that suggested 
a syndrome called Rubinstein-Taybi Syndrome (RSTS). 
Discussion
Rubbinstein-Taybi Syndrome is a rare multiple 
congenital anomaly with approximately 700 cases 
reported worldwide. It appears that there is very little 
documented evidence regarding this syndrome in 
pediatric and nephrologic literature (12).
The cause of RSTS is still unclear, but it is associated 
with a microdeletion at 16p 13.3 region in the CREB-
binding protein gene (CREBBP) in some patient, 
suggesting that deletion is the most probable cause of the 
syndrome (13). CREBBP is a transcription coactivator 
and functions as a potent histone acetyltransferase, both 
of which are essential to normal development (11).
In animal models, the mice with truncated Crb protein 
demonstrate clinical features of RSTS observed in 
humans including growth retardation, retarded osseous 
maturation, hypoplastic maxilla with a narrow palate, 
and cardiac and skeletal abnormalities (14).
More recently, the breakpoint of two distinct reciprocal 
translocations occurring in patients with the diagnosis 
of RSTS has been located in the same band 16p 13.3. 
However, this anomaly cannot be identified in all 
patients. Clinically, the difference between patients with 
or without deletion is minimal except for microcephaly. 
Band 16p 13.3 seems to be an important locus for mental 
retardation in patients with correct diagnosis of RSTS 
(9,15,16,17).
Our patient, a known case of CRF, had a high level of 
serum BUN and creatinine since her childhood. Urinary 
tract system is one of the multiple organ involvements in 
RST syndrome. Therefore, it was identified in our case 
report. She also had more characteristic features of the 
RSTS as explained above. 
In conclusion, RSTS is a rare genetic condition that affects 
body shape, extremities, and many organs/systems of 
the body, particularly cardiac, respiratory, nervous, and 
renal system. This case report can help pediatricians to 
become more familiar with this syndrome. 
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